A €14 Billion Backlog Can't Stop CSG's Slide — But a Single Day Might

European defense stock CSG N.V. trades near record lows amid ceasefire fears, but analysts see overreaction with €3.4T in EU defense spending ahead and strong fundamentals.

The numbers tell a story of a company firing on all cylinders. Revenue surged nearly 72% to €6.74 billion. The order book stands at €14 billion, with an additional €18 billion pipeline of high-probability deals. Analysts are unanimous in their bullishness — nine rate the stock a buy, none a sell, and the average price target sits at €35.40, with J.P. Morgan calling for €40.

Yet CSG N.V. closed Friday at €19.93, a fresh 52-week low. The stock has shed roughly 15% over the past month and sits more than 41% below its peak of €33.81. For a company that is Europe's second-largest producer of medium and large calibers and the global leader in small-caliber ammunition, the market's verdict is bewildering.

Geopolitics Triggered the Selloff, But Fundamentals May Not Support It

The immediate catalyst for the latest leg lower came from an unexpected corner: Ukraine. A government official signaled progress toward a ceasefire with Russia, sending European defense stocks into a tailspin. CSG lost 9.7% in a single session, while Rheinmetall fell 5.7% and Leonardo dropped roughly 5%.

Analysts argue the reaction is overdone. European defense budgets are undergoing a structural expansion that transcends the war in Ukraine. The European Commission estimates member states will spend €392 billion on defense this year, with a projected €3.4 trillion over the next decade. Even if a ceasefire materializes, Europe's depleted stockpiles will require years of replenishment. The macro backdrop remains firmly supportive.

Operational Strength That the Market Ignores

CSG's 2025 results underscore the disconnect. Revenue jumped nearly 72% year-over-year to €6.74 billion, while the EBIT margin hit 25.6% in 2024 and is expected to hold between 24% and 25% in the medium term. Management has guided for 2026 revenue of €7.4 billion to €7.6 billion, and J.P. Morgan projects €8.93 billion in revenue and €2.22 billion in EBIT by 2027.

Beyond the headline numbers, the company is expanding its footprint. Through its subsidiary Excalibur International, CSG secured contracts for air defense systems in Southeast Asia valued at nearly $2.5 billion, with deliveries spread over four to five years. It's a record order that diversifies revenue away from Europe.

Two Catalysts That Could Break the Spell

The stock's trajectory may hinge on two near-term events. First, CSG is awaiting regulatory approval for its acquisition of a 49% stake in Hirtenberger Defence Systems, an Austrian munitions specialist. A green light would remove a key overhang. The company is also acquiring a stake in Hungary's RÁBA Automotive Holding, signaling further strategic expansion.

Second, and perhaps more critically, CSG will publish its first quarterly report as a publicly listed company on May 20. It will be the market's first detailed look at the numbers since the January IPO. Investors will scrutinize margins closely — management needs to demonstrate it can sustain the targeted 24% operating margin amid industry-wide cost pressures.

A Market That Refuses to See the Forest

Technical indicators are flashing sell signals, and the stock's descent has been relentless since its debut. But the fundamental case remains compelling. Europe's NATO members are already exceeding the 2% GDP defense spending target, with some preparing to spend up to 5%. The structural demand for ammunition and defense systems is set to persist for years, regardless of the war's outcome.

CSG's order backlog of €14 billion, combined with the €18 billion pipeline, provides multi-year revenue visibility that few industrial companies can match. The gap between the current share price and the average analyst target of €35.40 represents potential upside of more than 77% — a disconnect that seems unsustainable.

The coming weeks will test whether the market's pessimism is justified or whether the fundamentals will eventually reassert themselves. The Hirtenberger decision and the first quarterly report offer two distinct opportunities for the narrative to shift. If the numbers confirm what analysts already see, the stock's slide may finally find a floor.